1.
Emerg Infect Dis
; 29(11): 2380-2382, 2023 11.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37705075
RESUMO
We conducted surveillance of respiratory syncytial virus (RSV) genomic sequences for 100 RSV-A and 27 RSV-B specimens collected during November 2022-April 2023 in Arizona, USA. We identified mutations within prefusion F-protein antigenic sites in both subtypes. Continued genomic surveillance will be critical to ensure RSV vaccine effectiveness.